Related Experiment Videos
Sarcoidosis after interferon therapy for chronic active hepatitis C
H Teragawa1, T Hondo, K Takahashi
1Department of Internal Medicine, Onomichi General Hospital.
Internal Medicine (Tokyo, Japan)
|January 1, 1996
Summary
Alpha-2a interferon (IFN) treatment for hepatitis C may trigger sarcoidosis, a multisystemic inflammatory disease. A patient developed sarcoidosis with heart block and lung granulomas after IFN therapy.
Area of Science:
- Immunology
- Hepatology
- Cardiology
Background:
- Sarcoidosis is a multisystemic granulomatous disease of unknown cause.
- Alpha-2a interferon (IFN) is used to treat chronic hepatitis C.
- Interferon therapy can modulate immune responses.